Literature DB >> 7377887

Management of patent ductus arteriosus in preterm babies.

R Gómez, F Moreno, M Burgueros, P A Sanchez, J Quero, F Alvarez.   

Abstract

There is a higher incidence of delayed closure of the patent ductus arteriosus in premature babies with respiratory distress syndrome. From July, 1975, to December, 1977, 57 small, preterm infants with patent ductus arteriosus were diagnosed at our neonatal intensive care unit. From July, 1975, until September, 1976 (first period), 23 patients were diagnosed, and 11 underwent surgical ligation of a patent ductus arteriosus. There were 3 early deaths. From October, 1976, until December, 1977, out of a total of 34 patients with diagnosed patent ductus, 18 were treated with indomethacin, and only 3 required ligation. Our present policy for patent ductus arteriosus with respiratory distress syndrome in the premature baby is to initiate early treatment with indomethacin. If this treatment fails and the infant's status deteriorates, we perform early surgical ligation of the ductus in order to minimize the time on mechanical ventilation and lessen the chances of the development of bronchopulmonary dysplasia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377887     DOI: 10.1016/s0003-4975(10)61679-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Hong Quan; Shibnath Ghatak; Toru Akaike; Eri Segi-Nishida; Shiho Iwasaki; Mari Iwamoto; Suniti Misra; Kouichi Tamura; Hideaki Hori; Shumpei Yokota; Bryan P Toole; Yukihiko Sugimoto; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.